An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab.

Recently, research has been focused on the identification of predictors of response to treatment in patients with active psoriatic arthritis (PsA). The objective of this study was to develop a model to predict the clinical response at 6 months in patients with PsA starting the anti-tumour necrosis factor-α golimumab.This prospective observational study explored a range of factors, including demographic data and baseline characteristics of the...